Gritstone Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Gritstone Technologies's estimated annual revenue is currently $25.2M per year.
- Gritstone Technologies's estimated revenue per employee is $159,500
Employee Data
- Gritstone Technologies has 158 Employees.
- Gritstone Technologies grew their employee count by 1% last year.
Gritstone Technologies's People
Name | Title | Email/Phone |
---|
Gritstone Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.4M | 6 | 0% | N/A | N/A |
#2 | $0.4M | 6 | 0% | N/A | N/A |
#3 | $42.1M | 264 | 6% | N/A | N/A |
#4 | $0.6M | 8 | 0% | N/A | N/A |
#5 | $1.6M | 18 | 6% | N/A | N/A |
#6 | $1.3M | 15 | -6% | N/A | N/A |
#7 | $0.4M | 6 | -14% | N/A | N/A |
#8 | $0.6M | 8 | 0% | N/A | N/A |
#9 | $2M | 27 | -27% | $4.9M | N/A |
#10 | $1.4M | 16 | 0% | N/A | N/A |
What Is Gritstone Technologies?
"Our mission is to inspire people to value their life." Gritstone Technologies is a product engineering firm, where we turn proofs-of-concept into market-ready products and scale them to achieve value and business goals.
keywords:N/AN/A
Total Funding
158
Number of Employees
$25.2M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Gritstone Technologies News
2022-04-20 - Neoantigen Cancer Vaccine Market Size, Scope And Forecast ...
Avidea Technologies, Agenus, Roche, Nouscom, Genocea Biosciences, Gritstone Oncology, Gilead Sciences, BioNTech, ISA Pharmaceutical, Vaccibody.
2022-04-19 - Byrne registers to lobby- POLITICO
Strategic Marketing Innovations: Advent Technologies Strategic Marketing Innovations: Textum ... The Kpm Group Dc LLC: Gritstone Oncology
2022-04-17 - Neoantigen Cancer Vaccine Market Size And Forecast ...
Avidea Technologies, Agenus, Roche, Nouscom, Genocea Biosciences, Gritstone Oncology, Gilead Sciences, BioNTech, ISA Pharmaceutical, Vaccibody.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $46.9M | 158 | -1% | N/A |
#2 | $15M | 158 | 37% | N/A |
#3 | $15M | 158 | 3% | N/A |
#4 | $15M | 159 | 14% | N/A |
#5 | $17.8M | 159 | 1% | N/A |